triolein and Metabolic-Diseases

Patients being investigated for intestinal absorptive capacity were classified as normals or malabsorbers on the basis of three fat absorption tests. Malabsorbers were further classified as mild, moderate, severe or gross according to severity of malabsorption. Using this classification system the triolein breath test was evaluated in 53 patients. Seventeen patients were excluded because their graph of percentage breath [14C]carbon dioxide versus time was exponential indicating that the peak [14C]-carbon dioxide may be occurring later than the six hour duration of the test. The sensitivity and specificity of the triolein breath test were found to be 100% and 96%, respectively and moderate correlations with the individual fat absorption tests were found. However, the breath test was limited in its capacity to predict the severity of malabsorption. Carbon dioxide output was also measured in order to determine the applicability of using an assumed value. The respiratory quotient and variability of results were high in nineteen patients indicating possible hyperventilation. In 32 patients with reproducible results and normal respiratory quotients the average carbon dioxide output was 8.66 mmol/kg per hour with a wide range of 5-12.4 mmol/kg per hour. Consequently the use of an assumed carbon dioxide output can introduce considerable errors in the triolein breath test. This study highlights drawbacks of the triolein breath test, particularly problems in using an assumed carbon dioxide output for its calculation, its inability to predict the severity of malabsorption and the nature of the dietary load used.

Topics: Adolescent; Adult; Aged; Aged, 80 and over; Breath Tests; Carbon Dioxide; Carbon Radioisotopes; Child; Chromium Radioisotopes; Fats; Feces; Humans; Intestinal Absorption; Malabsorption Syndromes; Metabolic Diseases; Middle Aged; Respiration Disorders; Triolein; Tritium

Topics: Aging; Coronary Disease; Fats, Unsaturated; Heart; Humans; Metabolic Diseases; Triolein

Topics: Aged; Coronary Artery Disease; Coronary Disease; Fats, Unsaturated; Heart; Humans; Metabolic Diseases; Triolein